This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.
Company Profile:
Curis, Inc.
Market Cap (USD):
$74.3 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
FibroGen, Inc.
Market Cap (USD):
$73.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
HOOKIPA Pharma Inc.
Market Cap (USD):
$73.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Enzolytics, Inc.
Market Cap (USD):
$71.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Cidara Therapeutics, Inc.
Market Cap (USD):
$70.3 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Cardiff Oncology, Inc.
Market Cap (USD):
$70.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Ocuphire Pharma, Inc.
Market Cap (USD):
$68.4 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
LogicBio Therapeutics, Inc.
Market Cap (USD):
$68.2 M
(Nov. 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Kronos Bio, Inc.
Market Cap (USD):
$67.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Kezar Life Sciences, Inc.
Market Cap (USD):
$66.9 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Biotech Products Services and Research, Inc.
Market Cap (USD):
$66.1 M
(Nov. 1, 2021)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
AVROBIO, Inc.
Market Cap (USD):
$65.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Immunic, Inc.
Market Cap (USD):
$62.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Anebulo Pharmaceuticals, Inc.
Market Cap (USD):
$61.5 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Gain Therapeutics, Inc.
Market Cap (USD):
$60.7 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Surface Oncology, Inc.
Market Cap (USD):
$59.2 M
(July 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Checkpoint Therapeutics, Inc.
Market Cap (USD):
$56.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Artemis Therapeutics, Inc.
Market Cap (USD):
$55.8 M
(May 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Reneo Pharmaceuticals, Inc.
Market Cap (USD):
$55.0 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Tyme Technologies, Inc.
Market Cap (USD):
$53.5 M
(Sept. 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Sigilon Therapeutics, Inc.
Market Cap (USD):
$53.3 M
(July 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Aligos Therapeutics, Inc.
Market Cap (USD):
$53.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Assembly Biosciences, Inc.
Market Cap (USD):
$53.2 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Passage Bio, Inc.
Market Cap (USD):
$50.8 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Instil Bio, Inc.
Market Cap (USD):
$50.1 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Immune Therapeutics, Inc.
Market Cap (USD):
$50.0 M
(July 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
TCR2 Therapeutics Inc.
Market Cap (USD):
$49.9 M
(Jan. 1, 2023)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Cleveland BioLabs, Inc.
Market Cap (USD):
$49.1 M
(June 1, 2022)
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Provectus Biopharmaceuticals, Inc.
Market Cap (USD):
$48.9 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology
Company Profile:
Aeglea BioTherapeutics, Inc.
Market Cap (USD):
$48.6 M
Country:
United States
Sector:
Healthcare
Industry:
Biotechnology